SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-22-008431
Filing Date
2022-03-31
Accepted
2022-03-31 16:06:16
Documents
88
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 2563939
2 ex10-53.htm EX-10.53 123214
3 ex10-54.htm EX-10.54 79127
4 ex10-55.htm EX-10.55 605325
5 ex21-1.htm EX-21.1 2156
6 ex23-1.htm EX-23.1 4047
7 ex31-1.htm EX-31.1 17115
8 ex31-2.htm EX-31.2 16902
9 ex32-1.htm EX-32.1 9217
10 form10-k_001.jpg GRAPHIC 19727
  Complete submission text file 0001493152-22-008431.txt   10360413

Data Files

Seq Description Document Type Size
11 XBRL SCHEMA FILE qlgn-20211231.xsd EX-101.SCH 75054
12 XBRL CALCULATION FILE qlgn-20211231_cal.xml EX-101.CAL 84064
13 XBRL DEFINITION FILE qlgn-20211231_def.xml EX-101.DEF 275270
14 XBRL LABEL FILE qlgn-20211231_lab.xml EX-101.LAB 559274
15 XBRL PRESENTATION FILE qlgn-20211231_pre.xml EX-101.PRE 421615
82 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 1501968
Mailing Address 2042 CORTE DEL NOGAL CARLSBAD CALIFORNIA CA 92011
Business Address 2042 CORTE DEL NOGAL CARLSBAD CALIFORNIA CA 92011 (760) 918-9165
Qualigen Therapeutics, Inc. (Filer) CIK: 0001460702 (see all company filings)

IRS No.: 263474527 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37428 | Film No.: 22792427
SIC: 2834 Pharmaceutical Preparations